MSP: An emerging player in metabolic syndrome

Cytokine and Growth Factor Reviews

Volumn 26, Issue 1, 2015, Pages 75-82

  Li, Jieyi ^b   Chanda, Dipanjan ^a   Shiri Sverdlov, Ronit ^b   Neumann, Dietbert ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Inflammation; Metabolic syndrome; MSP; RON

Indexed keywords

ADENYLATE KINASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; CYCLOOXYGENASE 2; GAMMA INTERFERON; GLUCOSE 6 PHOSPHATASE; HEPATOCYTE GROWTH FACTOR LIKE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 12P40; MACROPHAGE STIMULATING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT1 PROTEIN; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ACUTE LUNG INJURY; AMINO TERMINAL SEQUENCE; GLUCOSE METABOLISM; IN VIVO STUDY; INFLAMMATION; LIPID METABOLISM; METABOLIC REGULATION; METABOLIC SYNDROME X; NONHUMAN; PHAGOCYTOSIS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SHORT SURVEY; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HOMEOSTASIS; HUMANS; INFLAMMATION; LIPID METABOLISM; METABOLIC SYNDROME X; MICE; PROTO-ONCOGENE PROTEINS; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84922844659     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.10.007     Document Type: Short Survey

References (88)

1. Leonard E.J., Skeel A. A serum protein that stimulates macrophage movement, chemotaxis and spreading. Exp Cell Res 1976, 102:434-438.
2. Stuart W.D., Kulkarni R.M., Gray J.K., Vasiliauskas J., Leonis M.A., Waltz S.E. Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology (Baltimore, MD) 2011, 53:1618-1628.
3. McDowell S.A., Mallakin A., Bachurski C.J., Toney-Earley K., Prows D.R., Bruno T., et al. The role of the receptor tyrosine kinase Ron in nickel-induced acute lung injury. Am J Respir Cell Mol Biol 2002, 26:99-104.
4. Goyette P., Lefebvre C., Ng A., Brant S.R., Cho J.H., Duerr R.H., et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol 2008, 1:131-138.
5. Rampino T., Soccio G., Gregorini M., Guidetti C., Marasa M., Maggio M., et al. Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis. J Am Soc Nephrol 2007, 18:1486-1496.
6. Bezerra J.A., Carrick T.L., Degen J.L., Witte D., Degen S.J. Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. J Clin Invest 1998, 101:1175-1183.
7. Chanda D., Li T., Song K.H., Kim Y.H., Sim J., Lee C.H., et al. Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes. J Biol Chem 2009, 284:28510-28521.
8. Donate L.E., Gherardi E., Srinivasan N., Sowdhamini R., Aparicio S., Blundell T.L. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci 1994, 3:2378-2394.
9. Han S., Stuart L.A., Degen S.J. Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 1991, 30:9768-9780.
10. Yoshimura T., Yuhki N., Wang M.H., Skeel A., Leonard E.J. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 1993, 268:15461-15468.
11. Danilkovitch A., Miller M., Leonard E.J. Interaction of macrophage-stimulating protein with its receptor: residues critical for beta chain binding and evidence for independent alpha chain binding. J Biol Chem 1999, 274:29937-29943.
12. Rampino T., Collesi C., Gregorini M., Maggio M., Soccio G., Guallini P., et al. Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. J Am Soc Nephrol 2002, 13:649-657.
13. Wang M.H., Skeel A., Leonard E.J. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest 1996, 97:720-727.
14. Wang M.H., Yoshimura T., Skeel A., Leonard E.J. Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J Biol Chem 1994, 269:3436-3440.
15. Wang M.H., Gonias S.L., Skeel A., Wolf B.B., Yoshimura T., Leonard E.J. Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family. J Biol Chem 1994, 269:13806-13810.
16. Kawaguchi M., Orikawa H., Baba T., Fukushima T., Kataoka H. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. FEBS J 2009, 276:3481-3490.
17. Ganesan R., Kolumam G.A., Lin S.J., Xie M.H., Santell L., Wu T.D., et al. Proteolytic activation of pro-macrophage-stimulating protein by hepsin. Mol Cancer Res 2011, 9:1175-1186.
18. Orikawa H., Kawaguchi M., Baba T., Yorita K., Sakoda S., Kataoka H. Activation of macrophage-stimulating protein by human airway trypsin-like protease. FEBS Lett 2012, 586:217-221.
19. Bhatt A.S., Welm A., Farady C.J., Vasquez M., Wilson K., Craik C.S. Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc Natl Acad Sci USA 2007, 104:5771-5776.
20. Nanney L.B., Skeel A., Luan J., Polis S., Richmond A., Wang M.H., et al. Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury. J Invest Dermatol 1998, 111:573-581.
21. Quantin B., Schuhbaur B., Gesnel M.C., Doll'e P., Breathnach R. Restricted expression of the Ron gene encoding the macrophage stimulating protein receptor during mouse development. Dev Dyn 1995, 204:383-390.
22. Gaudino G., Avantaggiato V., Follenzi A., Acampora D., Simeone A., Comoglio P.M. The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 1995, 11:2627-2637.
23. Ronsin C., Muscatelli F., Mattei M.G., Breathnach R. A novel putative receptor protein tyrosine kinase of the met family. Oncogene 1993, 8:1195-1202.
24. Wang J., Steinbacher S., Augustin M., Schreiner P., Epstein D., Mulvihill M.J., et al. The crystal structure of a constitutively active mutant RON kinase suggests an intramolecular autophosphorylation hypothesis. Biochemistry 2010, 49:7972-7974.
25. Waltz S.E. Functional characterization of domains contained in hepatocyte growth factor-like protein. J Biol Chem 1997, 272:30526-30537.
26. Yao H.P., Zhou Y.Q., Zhang R., Wang M.H. MSP-RON signalling in cancer: pathogenesis and therapeutic potential. Nat Rev Cancer 2013, 13:466-481.
27. Wang M.H., Zhou Y.Q., Chen Y.Q. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand J Immunol 2002, 56:545-553.
28. Wang M.H., Zhang R., Zhou Y.Q., Yao H.P. Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction. J Biomed Res 2013, 27:345-356.
29. Skeel A., Leonard E.J. Action and target cell specificity of human macrophage-stimulating protein (MSP). J Immunol 1994, 152:4618-4623.
30. Lutz M.A., Correll P.H. Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C zeta. J Leukoc Biol 2003, 73:802-814.
31. Skeel A., Yoshimura T., Showalter S.D., Tanaka S., Appella E., Leonard E.J. Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity. J Exp Med 1991, 173:1227-1234.
32. Wang M.H., Cox G.W., Yoshimura T., Sheffler L.A., Skeel A., Leonard E.J. Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. J Biol Chem 1994, 269:14027-14031.
33. Correll P.H., Iwama A., Tondat S., Mayrhofer G., Suda T., Bernstein A. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct 1997, 1:69-83.
34. Waltz S.E., Eaton L., Toney-Earley K., Hess K.A., Peace B.E., Ihlendorf J.R., et al. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J Clin Invest 2001, 108:567-576.
35. Zhou Y.Q., Chen Y.Q., Fisher J.H., Wang M.H. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J Biol Chem 2002, 277:38104-38110.
36. Liu Q.P., Fruit K., Ward J., Correll P.H. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J Immunol 1999, 163:6606-6613.
37. Yuk J.M., Shin D.M., Lee H.M., Kim J.J., Kim S.W., Jin H.S., et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol 2011, 12:742-751.
38. Ray M., Yu S., Sharda D.R., Wilson C.B., Liu Q., Kaushal N., et al. Inhibition of TLR4-induced IkappaB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J Immunol 2010, 185:7309-7316.
39. Morrison A.C., Correll P.H. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J Immunol 2002, 168:853-860.
40. Chen Y.Q., Fisher J.H., Wang M.H. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J Immunol 1998, 161:4950-4959.
41. Wright K., Ward S.G., Kolios G., Westwick J. Activation of phosphatidylinositol 3-kinase by interleukin-13: an inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J Biol Chem 1997, 272:12626-12633.
42. Park Y.C., Lee C.H., Kang H.S., Chung H.T., Kim H.D. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages. Biochem Biophys Res Commun 1997, 240:692-696.
43. Morrison A.C., Wilson C.B., Ray M., Correll P.H. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 2004, 172:1825-1832.
44. Wilson C.B., Ray M., Lutz M., Sharda D., Xu J., Hankey P.A. The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. J Immunol 2008, 181:2303-2310.
45. O'Neill L.A., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013, 493:346-355.
46. Salminen A., Hyttinen J.M., Kaarniranta K. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med 2011, 89:667-676.
47. Sag D., Carling D., Stout R.D., Suttles J. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008, 181:8633-8641.
48. Bezerra J.A., Laney D.W., Degen S.J. Increased expression of mRNA for hepatocyte growth factor-like protein during liver regeneration and inflammation. Biochem Biophys Res Commun 1994, 203:666-673.
49. Harrison P., Degen S.J., Williams R., Farzaneh F. Hepatic expression of hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure. Lancet 1994, 344:27-29.
50. Laskin D.L., Chen L., Hankey P.A., Laskin J.D. Role of STK in mouse liver macrophage and endothelial cell responsiveness during acute endotoxemia. J Leukoc Biol 2010, 88:373-382.
51. Kulkarni R.M., Stuart W.D., Gurusamy D., Waltz S.E. Ron receptor signaling is protective against DSS-induced colitis in mice. Am J Physiol Gastrointest Liver Physiol 2014, 306:G1065-G1074.
52. Leonis M.A., Toney-Earley K., Degen S.J., Waltz S.E. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Hepatology (Baltimore, MD) 2002, 36:1053-1060.
53. Gorlatova N., Chao K., Pal L.R., Araj R.H., Galkin A., Turko I., et al. Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution. PLoS ONE 2011, 6:e27269.
54. Kauder S.E., Santell L., Mai E., Wright L.Y., Luis E., N'Diaye E.N., et al. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele. PLOS ONE 2013, 8:e83958.
55. Lentsch A.B., Pathrose P., Kader S., Kuboki S., Collins M.H., Waltz S.E. The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation. Shock 2007, 27:274-280.
56. Nikolaidis N.M., Kulkarni R.M., Gray J.K., Collins M.H., Waltz S.E. Ron receptor deficient alveolar myeloid cells exacerbate LPS-induced acute lung injury in the murine lung. Innate Immun 2011, 17:499-507.
57. Gunella G., Bardelli C., Amoruso A., Viano I., Balbo P., Brunelleschi S. Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway. Br J Pharmacol 2006, 148:478-489.
58. Arakelyan A., Kriegova E., Kubištova Z., Mrazek F., Kverka M., Du Bois R.M., et al. Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis. Clin Exp Immunol 2009, 155:457-465.
59. Lee K.E., Kim E.Y., Kim C.S., Choi J.S., Bae E.H., Ma S.K., et al. Macrophage-stimulating protein attenuates gentamicin-induced inflammation and apoptosis in human renal proximal tubular epithelial cells. Biochem Biophys Res Commun 2013, 434:527-533.
60. Cantaluppi V., Biancone L., Romanazzi G.M., Figliolini F., Beltramo S., Galimi F., et al. Macrophage stimulating protein may promote tubular regeneration after acute injury. J Am Soc Nephrol 2008, 19:1904-1918.
61. Tong X.M., Wang J.C., Shen Y., Xie J.J., Zhang J.Y., Jin J. Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts. Inflamm Res 2011, 60:823-829.
62. Caldwell C.C., Martignoni A., Leonis M.A., Ondiveeran H.K., Fox-Robichaud A.E., Waltz S.E. Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Crit Care Med 2008, 36:1585-1593.
63. Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 2009, 9:407-416.
64. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (New York, NY) 1991, 251:802-804.
65. Tsukagawa E., Adachi H., Hirai Y., Enomoto M., Fukami A., Ogata K., et al. Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10-year prospective study. Clin Endocrinol 2013, 79:43-48.
66. Boros P., Miller C.M. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995, 345:293-295.
67. Gentile A., Trusolino L., Comoglio P.M. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008, 27:85-94.
68. Nakamura T., Sakai K., Nakamura T., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol 2011, 26(Suppl. 1):188-202.
69. Giebeler A., Boekschoten M.V., Klein C., Borowiak M., Birchmeier C., Gassler N., et al. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology 2009, 137:297-308. e1-4.
70. Gong R., Rifai A., Dworkin L.D. Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium. J Am Soc Nephrol 2006, 17:2464-2473.
71. Gong R., Rifai A., Dworkin L.D. Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin. Kidney Int 2006, 69:1166-1174.
72. Kusunoki H., Taniyama Y., Otsu R., Rakugi H., Morishita R. Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes. Hypertens Res 2014, 37:500-506.
73. Hiratsuka A., Adachi H., Fujiura Y., Yamagishi S., Hirai Y., Enomoto M., et al. Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 2005, 90:2927-2931.
74. Rajpathak S.N., Wassertheil-Smoller S., Crandall J., Liu S., Ho G.Y. Hepatocyte growth factor and clinical diabetes in postmenopausal women. Diabetes Care 2010, 33:2013-2015.
75. Kato Y., Yu D., Schwartz M.Z. Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection. J Pediatr Surg 1998, 33:13-15.
76. Bertola A., Bonnafous S., Cormont M., Anty R., Tanti J.F., Tran A., et al. Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway. J Biol Chem 2007, 282:10325-10332.
77. Garcia-Ocana A., Vasavada R.C., Cebrian A., Reddy V., Takane K.K., Lopez-Talavera J.C., et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 2001, 50:2752-2762.
78. Roccisana J., Reddy V., Vasavada R.C., Gonzalez-Pertusa J.A., Magnuson M.A., Garcia-Ocana A. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes 2005, 54:2090-2102.
79. Demirci C., Ernst S., Alvarez-Perez J.C., Rosa T., Valle S., Shridhar V., et al. Loss of HGF/c-Met signaling in pancreatic beta-cells leads to incomplete maternal beta-cell adaptation and gestational diabetes mellitus. Diabetes 2012, 61:1143-1152.
80. Perdomo G., Martinez-Brocca M.A., Bhatt B.A., Brown N.F., O'Doherty R.M., Garcia-Ocana A. Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J Biol Chem 2008, 283:13700-13706.
81. Fafalios A., Ma J., Tan X., Stoops J., Luo J., Defrances M.C., et al. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med 2011, 17:1577-1584.
82. Alvarez-Perez J.C., Ernst S., Demirci C., Casinelli G.P., Mellado-Gil J.M., Rausell-Palamos F., et al. Hepatocyte growth factor/c-Met signaling is required for beta-cell regeneration. Diabetes 2014, 63:216-223.
83. Mellado-Gil J., Rosa T.C., Demirci C., Gonzalez-Pertusa J.A., Velazquez-Garcia S., Ernst S., et al. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Diabetes 2011, 60:525-536.
84. Park M.K., Kim D.K., Lee H.J. Adenoviral mediated hepatocyte growth factor gene attenuates hyperglycemia and beta cell destruction in overt diabetic mice. Exp Mol Med 2003, 35:494-500.
85. Tomita K., Azuma T., Kitamura N., Nishida J., Tamiya G., Oka A., et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 2004, 126:873-885.
86. Kosone T., Takagi H., Horiguchi N., Ariyama Y., Otsuka T., Sohara N., et al. HGF ameliorates a high-fat diet-induced fatty liver. Am J Physiology Gastrointest Liver Physiol 2007, 293:G204-G210.
87. Kroy D.C., Schumacher F., Ramadori P., Hatting M., Bergheim I., Gassler N., et al. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic-steatohepatitis in mice. J Hepatol 2014, 61:883-890.
88. Bezerra J.A., Witte D.P., Aronow B.J., Degen S.J. Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology (Baltimore, MD) 1993, 18:394-399.